Medicine recalls
|
| |
| Australia: BTC Rosuvastatin 10 mg tablets: Recall - potential missing blister sheets |
| |
Consumers and health professionals are advised that Apotex, in consultation with the Therapeutic Goods Administration (TGA), is recalling one batch of BTC Rosuvastatin 10 mg tablets (batch number F4250, expiry date 08/2019).
It has been identified that this medicine may have been dispensed with missing blister sheets, which means affected packs would not contain the correct amount of tablets.
BTC Rosuvastatin 10 mg tablets are used to lower high cholesterol levels.
Apotex has written to pharmacists providing further information about this issue, including details of the recall process.
Consumers are advised to return any unused medicine to their pharmacies for a refund and/or to arrange alternative medicine if they have a pack that has been affected by this issue.
Health professionals are advised to inspect their stocks and quarantine all packs from the affected batch before returning them to their wholesalers.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/btc-rosuvastatin-10-mg-tablets
In Hong Kong, there is a registered tablet containing active ingredient of rosuvastatin 10mg per tablet under the brand name APO-ROSUVASTATIN TABLET 10MG (HK61458), manufactured by APOTEX INC. in CANADA. The product is registered by HIND WING CO LTD (Hind Wing) and is a prescription only medicine. As confirmed with Hind Wing, the recall in Australia has no impact on the products marketed in Hong Kong.
Ends/ Saturday, May 27, 2017
Issued at HKT 12:00
Content last updated: Monday, May 29, 2017.
|
| |
